Medical Advisory Committee (MAC)
Comprised of selected primary care and specialty physicians from across the HealthCare Partners Network, the Medical Advisory Committee (MAC) meets monthly with HCP staff physicians and managers to discuss critical clinical and healthcare management issues of relevance to our members and participating physicians. The MAC provides invaluable input on these issues to the organization, and assists HCP in communicating important information to the healthcare community.
For questions regarding content, please email Dr. Joseph S. Cervia at jcervia@hcpipa.com
HCPartnership Meetings
On a recurring basis, HCP invites our Primary Care Physicians to attend regional Medical Advisory Committee dinner meetings called HCPartnership Meetings.
The PCPs are asked to provide unbiased feedback, help explore the state of the marketplace, assess presented strategic concepts and share suggestions to enhance our relationship with you and your patients. Attendees are offered an honorarium for their time.
Please contact your Provider Relations Specialist to learn more about upcoming meetings or to reserve your seat at the next meeting.
MAC Presentations
Presentations from previous meetings are included below for your reference.
Topics presented by Dr. Joseph Cervia from 5/25/2021 include:
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
- Public Trust and Willingness to Vaccinate Against COVID-19 in the US from October 14, 2020 to March 29, 2021
- Despite Big Buildup, Few Benefit From Medicare’s Advance Care Planning Coverage
Topics presented by Dr. Joseph Cervia from 4/27/2021 include:
- COVID-19 Distancing Schools
- Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19
- The Coronavirus Pandemic 1 Year On – What Went Wrong? (The JAMA Forum)
Topics presented by Dr. Joseph Cervia from 2/23/2021 include:
- Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers
- The NEW ENGLAND JOURNAL OF MEDICINE Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results
- Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomized, controlled, open-label, platform Trial Early High-Tier Plasma Therapy to Prevent Severe COVID-19 in Older Adults
Topics presented by Dr. Joseph Cervia from 1/27/2021 include:
- Early High-Titer Plasma Therapy to Prevent Severe COVID-19 in Older Adults
- Efficacy and Safety of the Moderna COVID-19 Vaccine
- Efficacy and Safety of the Pfizer COVID-19 Vaccine
Topics presented by Dr. Joseph Cervia from 12/15/2020 include:
- COVID-19 Herd Immunity
- COVID-19 Mortality
- Answering Key Questions About COVID-19 Vaccines
- Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19
Topics presented by Dr. Joseph Padula and Dr. Joseph Cervia from 7/28/2020 include:
- Surviving Mechanical Ventilation in COVID Lung Disease – or Not: Dr. Joseph Padula
- Medical Policy Updates: Dr. Joseph Cervia
- Site of Service Utilization: Commercial/Medicaid
- Acupuncture for Chronic Lower Back Pain: Medicare
- Amniotic Membrane Transplantation for Ocular Reconstruction
- Bone Mineral Density Studies in Adult Populations
- Gender Affirming/Reassignment Surgery
Topics presented by Dr. Joseph Cervia on 6/30/2020 include:
- Back to the Future: How Lessons from one Pandemic May Save Lives in Another
- Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19:
- Medical Policy Updates
- Functional Endoscopic Sinus Surgery (FESS)
- Glaucoma Surgery
- MYvantage® Hereditary Comprehensive Cancer Panel
- Posterior Tibial Nerve Stimulation for Voiding Dysfunction
- Rhinoplasty
Topics presented by Dr. Joseph Cervia on 5/27/2020 include:
- Management of Critically Ill Adults with COVID-19
- Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19) A Review
- Other Clinicians and the Surge in Novel Coronavirus Disease 2019 (COVID-19)
Topics presented by Dr. Joseph Cervia on 4/28/2020 include:
- 2019 Novel Coronavirus: SARS VoV-2/COVID-19
- Presenting Characteristics, Comorbidities, and Outcomes Among 5,700 Patients Hospitalized with COVID-19 in the NYC Area
